Trade talks between the U.S. and Canada fell apart over the weekend, and the U.S. imposed 50% tariffs on $20 billion worth of Canadian goods.
Only about one-third of employers cover GLP-1s to treat obesity, leaving many patients facing prohibitively high drug costs on their own.